DenialHelp
Stelara (ustekinumab) Cost
IL-12/23 inhibitor; Wezlana biosimilar launching
category
Pharmacy
priceRange
$10,000-$25,000 per dose; biosimilars now FDA-approved
title
Stelara (ustekinumab) Cost
category
Pharmacy
price Range
$10,000-$25,000 per dose; biosimilars now FDA-approved
summary
IL-12/23 inhibitor; Wezlana biosimilar launching
savings Tips
- Biosimilar (Wezlana) when available
- Patient assistance
Related
Appeal your denial with DenialHelp
Upload your denial letter — DenialHelp drafts a physician-ready appeal in five minutes. $39 first-level appeal, money back if we can't draft a strong appeal.
Get started →Contact: hello@denialhelp.com